| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.9 |